Final Conference Program - aatod

More documents

Recommendations

Info

Pre-Conference Sessions Sunday, October 24, 2010 8:00 a.m.–5:30 p.m. Waldorf Opioid Maintenance Pharmacotherapy: A Course for Clinicians Laura McNicholas, MD, Philadelphia Veterans Administration Medical Center, Philadelphia, PA Susan Neshin, MD, JSAS Healthcare, Inc., Asbury Park, NJ J. Thomas Payte, MD, Colonial Management Group, LP, Orlando, FL Trusandra Taylor, MD, JEVS Human Services, Philadelphia, PA This course is recommended for clinicians with experience and/or interest in the medication-assisted treatment of opioid dependence. This program provides basic and state-of-the-art information. The curriculum is updated to include current consensus guidance for best practice treatment for opioid addiction. Topics include over - view of opioid dependence, epidemiology, opioid pharmacology/ neurobiology; evidence-based treatment options, patient assessment/ selection, special populations, induction and maintenance protocols, pain management, drug-to-drug interactions, adverse effects, methadone deaths, managing medical/ psychiatric problems, drug testing, regulatory issues, an accreditation update, risk management and an overview of buprenorphine. Participants will receive a comprehensive syllabus with reference and resource materials. The curriculum will include relevant case study discussion with audience participation to facilitate the learning process. To further integrate the educational objectives, participants are encouraged to discuss challenging problems and clinical issues to facilitate understanding of didactic principles. Four experienced opioid treatment program medical directors will conduct the program, focusing on the goal for participants to acquire the essential knowledge and skills necessary to deliver safe and effective medication-assisted treatment for patients with opioid dependence. The $175.00 registration fee includes a morning coffee service, afternoon luncheon and the evening’s Welcome Reception. Sponsored by the American Association for the Treatment of Opioid Dependence, Inc. and the American Society of Addiction Medicine, in cooperation with the American Academy of Addiction Psychiatry and the American Osteopathic Academy of Addiction Medicine. Supported by the National Institute on Drug Abuse. AMA PRA Category 1 Credit approved. 8:30 a.m.–5:00 p.m. Continental A Partnership Development for OTPs Maxine Fuller, MS, McKinley Group, Inc., Sandy Springs, GA Partnership development is a strategy that many organizations are using to enhance their ability to design, fund and provide services. The one-day Partnership Development for Opioid Treatment Programs Workshop will provide participants with the skills and tools necessary to identify, recruit and maintain effective partnerships. This is a hands-on and interactive workshop that will allow the participants to leave with a partnership development plan and effective implementation strategies and resources. In addition to the objectives stated above, completion of this workshop will enable participants to: • Determine if partnering is the correct strategy for their organizations • Identify partnership implementation tools and resources The topics the workshop will cover include: • Benefits and Challenges of Partnering • Partnership Assessment Exercise • Create Partnership Development Plans For session effectiveness, participation is limited to first 50 attendees who arrive for the session. Sponsored by the Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment (SAMHSA/CSAT). 8:30 a.m.–12:30 p.m. Continental C Buprenorphine for Nurses Colleen LaBelle, RN, Boston Medical Center, Boston, MA Sara Azimi-Bolourian, MSN, SAMHSA, Rockville, MD Hilary Jacobs, LICSW, Bureau of Substance Abuse Services, Massachusetts Department of Public Health, Boston, MA This Pre-Conference session introduces a new guideline titled “Buprenorphine: A Guide for Nurses”. It was published by the Substance Abuse and Mental Health Services Administration (SAMHSA) as the 30th publication in the Technical Assistant Publication Series (TAP #30). This Pre-Conference session is intended to provide nurses with general information about buprenorphine products—Suboxone® (buprenorphine and naloxone) and Subutex® (buprenorphine)—for the pharmacological treatment of opioid addiction. It covers screening, assessment, and diagnosis of opioid dependence and its associated problems and contains detailed protocols for the use of buprenorphine under a variety of clinical scenarios, including the use of buprenorphine with patients who are experiencing co-occurring pain or psychiatric disorders, or chemical dependency involving more than one substance. 6 AATOD National Conference | Building Partnerships: Advancing Treatment & Recovery
The session also provides nurses with a comprehensive overview of nursing roles in screening and assessing the health status of patients who have addiction problems. Moreover, the session focuses on nurses’ instrumental roles in the development and ongoing monitoring of treatment plans for patients who are on buprenorphine treatment and counseling and referral for psychosocial treatment. This session will assist nurses in developing improved understanding of the complexities of addictions treatment, and will promote better treatment outcomes by utilizing a team approach to patients’ opioid dependence. Sara Azimi-Bolourian will provide introductory remarks and a brief overview of the federal requirements for buprenorphine prescription and nursing roles. Colleen LaBelle will lead the session afterwards and provide information on the pharmacology of buprenorphine, detailed protocols for the use of buprenorphine under a variety of clinical scenarios, and protocols on the use of buprenorphine for medically supervised withdrawal, for classifications of medically supervised withdrawal, and for maintenance treatment. She will also describe the advantages and challenges of providing office-based treatment. Sponsored by the Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment (SAMHSA/CSAT). 9:00 a.m.–12:00 p.m. Continental B Opioid Treatment Program Accreditation— Town Hall Meeting Megan Marx, MPA, The Joint Commission, Oakbrook Terrace, IL Mary Cesare-Murphy, PhD, The Joint Commission, Oakbrook Terrace, IL This session will provide Joint Commission accredited organizations with an update on changes/revisions planned for accreditation standards and elements of performance in the Comprehensive Accreditation Manual for Behavioral Health Care (CAMBHC). The Joint Commission has recently completed a standards improvement initiative aimed at streamlining standards and elements of performance, and tailoring the survey process. A review of these changes, as well as a review of changes made to the format and structure of the CAMBHC electronically, to more effectively utilize the manual in their quality improvement processes and their continuous accreditation readiness efforts, will be discussed. We also intend to have our OTP account representatives and standards interpretation staff available during this session to meet with the organizations face-to-face and provide feedback to them about the survey application process and standards interpretation. We intend to use a Q&A format for this part of the session, after pro - viding participants with background information about the roles and responsibilities these two work groups represent. The two speakers will share time equally during the presentation. The account representatives and the standards interpretation staff member will participate during the last 30–45 minutes of the presentation, as needed. Sponsored by The Joint Commission. 9:00 a.m.–12:00 p.m. Marquette US and Vietnam: Celebrating 15 Years of Relations, 1995-2010 The efforts of AATOD and EUROPAD to create a world federation dedicated to the treatment and understanding of opioid dependence has far reaching influence. We are fortunate to have a delegation from Vietnam making a presentation at this conference. Under the sponsorship of PEPFAR -VN, and coordinated by the Substance Abuse and Mental Health Services Administration (SAMHSA), representatives from Vietnam will discuss the following: 1. Establishing a Prevention Strategy for HIV: Medicated Assisted Therapy; Vietnam Situation: An Overview of the HIV Epidemic and Response—Kevin P. Mulvey, PHD, Substance Abuse and Mental Health Services Administration (SAMHSA) 2. Substance Abuse Treatment Advisor, PEPFAR-SAMHSA VN: Establishing Political Will and Investment in a New Prevention/Treatment Option in Vietnam—Dr. Long, Vietnamese HIV/AIDS and Control, Ministry of Health, Hanoi Vietnam (TBA) 3. Medication Assisted Therapy in Vietnam: A Clinical Perspective—Dr. Thuy, Le Chan Clinic, Hai Phong 4. Technical Assistance Demands and Needs in Establishing Medication Assisted Therapy—Dr. Nhu To, Family Health International, Hanoi Vietnam 9:00 a.m.–5:30 p.m. Astoria NIATx OTP Project (invitation only) Kimberly Johnson, MBA, University of Wisconsin, Madison, WI Lynn Madden, MPA, APT, New Haven, CT Tom Zastowny, PhD, Webster, NY This session will be the wrap up session for the CSAT funded NIATx OTP project. The project is a year-long effort for 30 providers to improve access to and retention in treatment. The goal of the day will be to celebrate success, share stories and learn some tools and techniques for spreading improvements through the agency when there are multiple sites and sustaining improvement over time once the project is complete. October 23–27, 2010 | Hilton Chicago, Chicago, Illinois 7
Page 1 and 2: NATIONAL CONFERENCE Building Partne
Page 3 and 4: LETTER FROM THE CONFERENCE CHAIR De
Page 5 and 6: Pre-Conference Sessions Saturday, O
Page 7: MODULE DESCRIPTIONS Module One: Int
Page 11 and 12: disorders, medical care and vocatio
Page 13 and 14: Southwest Hall 16 Sex and Drug Usin
Page 15 and 16: presented will include neonatal and
Page 17 and 18: This workshop will preview and disc
Page 19 and 20: will discuss the collaborative proc
Page 21 and 22: with serum levels, and collaborativ
Page 23 and 24: Conference Sessions Wednesday, Octo
Page 25 and 26: F5 Using Patient Chart Audits to Im
Page 27 and 28: ecap and a valuable training tool t
Page 29 and 30: Sweet Home Chicago “C’mon, Oh b
Page 31 and 32: Alkermes, Inc. is a fully integrate
Page 33 and 34: medical, social, and public health
Page 35 and 36: Continuing Education SAMHSA is a pu

Final Conference Program - aatod

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?